EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY 4.0

A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness

Carlo Maria Bellanca, Simone Pietro Polosa, Egle Augello, Giulia Di Benedetto, Chiara Burgaletto, Anna Flavia Cantone, Gabriella Gaudio, Giuseppe Nunnari, Davide Campagna, Jennifer M Nailes, Hamza Shahbaz, Reza Kurniawan Tanuwihardja und 5 weitere

Frontiers in Pharmacology · 16.07.2025 · 16

DOI: 10.3389/fphar.2025.1606150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.07.2025. Verfasst von Carlo Maria Bellanca und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization (WHO) ranks tuberculosis (TB) as one of the top 10 causes of deaths worldwide. Notably, tobacco smoking represents a significant promoting factor in TB progression, being associated with poorer treatment outcomes, delayed conversion to negative smear or culture, and higher dropout rates from treatment plans. Remarkably, high rates of smoking and TB frequently overlaps in the same countries, warranting the need for targeted public health interventions. Prioritising smoking cessation is essential for smokers with TB, as sustained abstinence has been associated with reduced mortality and a more successful cure. This review examines the intricate relationship between cigarette smoking, smoking cessation therapies and anti-TB drugs, focusing on the impact of tobacco smoking compounds on liver detoxifying systems, such as influence of polycyclic aromatic hydrocarbons (PAHs) on hepatic cytochrome P450 (CYP450) enzymes mostly, and on metabolism of antituberculous medications. Integrating smoking cessation and TB treatment programmes must also take into account potential drug-drug interactions between smoking cessation medications and anti-TB drugs, a critical area for patient safety and effective TB management. This review article aims to provide healthcare professionals with the knowledge to better support TB patients who smoke or are intending to quit, to ensure tailored and effective treatment strategies, while highlighting gaps in current research and advocating for further studies to fill these gaps.

Schlagwörter

Stichwörter der Autor:innen

adverse drug reactionsantibioticscytochrome P450drug-drug interactionsnicotinesmoking cessation

Autor:innen und Institutionen

  • Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy.
  • Clinical Toxicology Unit, University Hospital of Catania, Catania, Italy.
  • Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
  • Department of Biochemical Engineering, University College London, London, United Kingdom.
  • Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, ARNAS Garibaldi Hospital of Catania, Catania, Italy.
  • Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy.

Zitieren

APA

Bellanca, C. M., Polosa, S. P., Augello, E., Di Benedetto, G., Burgaletto, C., Cantone, A. F., Gaudio, G., Nunnari, G., Campagna, D., Nailes, J. M., Shahbaz, H., Tanuwihardja, R. K., Mohan, A., Ceccarelli, M., Bernardini, R., Marino, A., & Cantarella, G. (2025). A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1606150

Vancouver

Bellanca CM, Polosa SP, Augello E, Di Benedetto G, Burgaletto C, Cantone AF, et al. A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1606150

BibTeX
@article{Bellanca2025,
  author = {Bellanca, Carlo Maria and Polosa, Simone Pietro and Augello, Egle and Di Benedetto, Giulia and Burgaletto, Chiara and Cantone, Anna Flavia and Gaudio, Gabriella and Nunnari, Giuseppe and Campagna, Davide and Nailes, Jennifer M and Shahbaz, Hamza and Tanuwihardja, Reza Kurniawan and Mohan, Anant and Ceccarelli, Manuela and Bernardini, Renato and Marino, Andrea and Cantarella, Giuseppina},
  title = {A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1606150}
}
Kostenlos starten →